Barbara Lindheim | Consulting Vice President Investor & Public Relations |
Dale Pfost | Chairman & Chief Executive Officer |
Don Marvin | Chief Financial Officer, Executive Vice President and Chief Operating Officer |
Adi Mor | Co-Founder and Chief Scientific Officer |
David Weiner | Interim Chief Medical Officer |
Kristen Kluska | Cantor Fitzgerald |
Jeff Jones | Oppenheimer |
Greetings, and welcome to Chemomab's Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only-mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Barbara Lindheim, Vice President of Strategic Communications.